Fritextsökning
Innehållstyper
-
"An open mind is the key to successful meetings"
Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...
-
Pengaregn över forskare
Långvariga infektioner, smärta och mitokondriernas genuttryck är några av de ämnen som delar på pengarna när Knut och Alice Wallenbergs Stiftelse delar ut 752 m...
-
Oncopeptides har ansökt om tillstånd för kliniska studier i USA
Oncopeptides planerar att påbörja kliniska studier i USA med deras andra läkemedelskandidat för patienter med multipelt myelom.
-
With their hands on the legal levers
It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Future drugs from Amaryllis
A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...
-
Samtycke från patient – i många fall inte tillräckligt för databehandling
Vilka är konsekvenserna av att den Europeiska dataskyddsstyrelsen uttalat att försökspersoner i de flesta fall inte kan samtycka till hantering av data rörande ...
-
Minifabriker effektiviserar läkemedelstillverkning
Bernt Nilsson och hans forskargrupp bygger små fabriker på labbet för att utveckla tillverkningsprocessen av biologiska läkemedel.
-
Samuel Lagercrantz: Samarbete och samverkan är nyckeln till framgång
Trots att många frågor om covid-19 fortfarande är obesvarade har utvecklingen av läkemedel och vaccin gått otroligt snabbt, skriver Samuel Lagercrantz i en ledare.
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
BREAKING